Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astatine-211-labeled gold nanoparticle–single-domain antibody conjugate ([211At]At-AuNP-ABDMPL16) is a preclinical-stage targeted alpha therapy (TAT) radiopharmaceutical. It consists of a single-domain antibody (ABDMPL16) targeting programmed cell death 1 ligand 1 (PD-L1) stably conjugated to the surface of a gold nanoparticle (AuNP) core and radiolabeled with the alpha-emitting radionuclide astatine-211 (211At). The gold nanoparticle platform provides high radiochemical stability and prevents deastatination in vivo, while the single-domain antibody ensures rapid tumor penetration and highly specific targeting of PD-L1-expressing cancer cells. Upon internalization, the high-energy, short-range alpha particles emitted by astatine-211 induce lethal double-strand DNA breaks in tumor cells, minimizing damage to surrounding healthy tissues. It is being investigated for the treatment of solid tumors, particularly melanoma.
| Indication | Highest phase | Status |
|---|---|---|
| melanoma | Preclinical | Active |
Every indication, with countries and timelines, is in the full profile.
| Market | Status | Year |
|---|---|---|
| United States | Not approved | — |
| European Union | Not approved | — |
| China | Not approved | — |
| Japan | Not approved | — |
Approved indications and other markets are in the full profile.
Lead indication: melanoma
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astatine-211-labeled gold nanoparticle–single-domain antibody conjugate.
Work on astatine-211-labeled gold nanoparticle–single-domain antibody conjugate? Claim this page to correct or add information. Claim this page